Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma

Authors :: Alexandre Vinaud Hirayama
Salvatore Fiorenza
Jordan Gauthier
Jenna M. Voutsinas
Qian Vicky Wu
Erik L. Kimble
Barbara S. Pender
Delaney R. Kirchmeier
Henna A. Di
Ryan D. Cassaday
Aude G. Chapuis
Damian J. Green
Hans-Peter Kiem
Filippo Milano
Mazyar Shadman
Brian G. Till
Stanley R. Riddell
David G. Maloney
Cameron J. Turtle
Source :: Blood. 140:7447-7449
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools